Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akero, Anavex, Biondvax, Biontech, Context, Corcept, Daiichi, Durect, Eyenovia, Ipsen, Matinas, Oncolys, Pfizer, Polypid, Revance, Timber, Vasopharm.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aerus, Ancora Heart, Corelink, Endra Life Sciences, Illuminoss Medical, Kardium, Livsmed, Qure.ai, Seegene.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Activ Surgical, Alberta Health Services, Ambu, Ascom, Biocorp, Blueprint Medicines, Ci Security, Coeus Consulting, C-Rad, Cylera, Dermtech, Endbraincancer Initiative, Flir Systems, Forest Devices, Fuel Medical Group, Gt Medical Technologies, Helferapp, Humana, Innominds Software, Ion Beam Applications, Labcorp, Leica Microsystems, Luminex, Medigate, Mindmaze, Novavision, Mirador Global, Mobidiag, Ordr, Oxitone Medical, Plano, Pra Health Sciences, Pressure Biosciences, Proscia, Protxx, Quest Diagnostics, Roche, Royal Philips, Santen Pharmaceutical, Sauber Engineering, Stryker, Trialjectory, Twist Bioscience, Vericel, Vycor Medical, Walmart, Wright Medical Group.

The latest global regulatory news, changes and updates affecting biopharma.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alterity, Ardelyx, Astrazeneca, Bioinvent, Mediwound, Merck, Nuvox, Oncopeptides, Oncternal, Osmotica, Prestige, Sparingvision, Synthetic Biologics, Vericel, Verrica.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advanced Accelerator, Audentes, Basilea, Bioasis, Blueprint, Burning Rock, Camino, CNS, Cstone, Genespire, Hoth, Immatics, Marker, Meissa, Novartis, Optinose, Vertex, Ziphius.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alnylam, Altimmune, Amniox, Aobiome, Beyondspring, Blueprint, Can-Fite, Depuy, Exelixis, Galectin, Genmab, Humanigen, Impel, Inovio, Iveric, Marinus, Meissa, Nordic Nanovector, Novartis, Noxxon, Oncternal, Orexo, Orthocell, Reneuron, Revance, Rheacell, Roche, Rubius, Seattle Genetics, Zynerba.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: 9 Meters, Achieve, Aileron, Biocardia, Cytodyn, Immutep, Immunovant, Intra-Cellular, Iterum, Kiniksa, KPB, Medicure, Revimmune, TFF, Tonix.